Hipertenzija je ubojica broj jedan za žene i važan je čimbenik rizika za oštećenje ciljnih organa. Žene tijekom reproduktivnog života rjeđe razvijaju arterijsku hipertenziju nego muškarci, ali u menopauzi njihov rizik sustiže i premašuje muškarce. Postoji nedostatak znanja o specifičnostima arterijske hipertenzije u žena zbog premalog uključivanja žena u klinička ispitivanja. Hipertenzivni poremećaji tijekom trudnoće priznati su skriveni čimbenik kardiovaskularnog rizika i opstetrička anamneza mora biti dio evaluacije žena s hipertenzijom. I endogeni i egzogeni ženski spolni hormoni utječu na krvni tlak tijekom života sa specifičnim karakteristikama koje se odnose na trudnoću, dojenje, oralne kontraceptive, menopauzu, hormonsku supstituciju i starije žene. Malo je podataka o specifičnoj terapiji antihipertenzivnim lijekovima kao i o izboru lijekova, njihovoj učinkovitosti i nuspojavama tijekom životnog vijeka žena.Hypertension in women is the number one killer and a vital risk factor for target organ damage. During reproductive life, women develop arterial hypertension less often than men, but in menopause their risk reaches and exceeds that of men. There is a shortage of knowledge on the specifics of arterial hypertension in women due to their insufficient inclusion in clinical trials. Hypertensive disorders during pregnancy are a known hidden cardiovascular risk factor, and obstetric anamnesis must be part of the evaluation of women with hypertension. Both endogenous and exogenous female sex hormones affect blood pressure throughout life, with specific characteristics related to pregnancy, breastfeeding, oral contraceptives, menopause, hormone replacement, and senior women. There is little data on specific therapy with antihypertensive drugs, as well as on the choice thereof, their efficiency and side effects, during a woman’s lifetime
